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Purpose: The current study aims to evaluate both safety and efficacy of Verisyse™ (AMO, 
Irvine, CA) phakic anterior chamber intraocular lens (IOL) in the reduction of clinically 
significant (-8 D) myopic anisometropia in children who are noncompliant to traditional 
medical treatment including spectacle correction or contact lenses.
Design: Retrospective interventional case series.
Methods: Six anisometropic myopic pediatric patients in one practice were identified through 
chart-review. None of the patients were compliant with specatacle correction or contact lens 
wear and as a result had dense amblyopia of less than 20/400 by Snellen or Allen visual acuity 
(mean 20/400). All patients underwent Verisyse™ phakic IOL implantation in the more myo-
pic eye by one surgeon (AP). Pre- and post-operative visual acuity, anterior/posterior segment 
examination, stereoacuity, axial biometry measurements, cycloplegic refraction, and endothelial 
cell counts were performed in all patients whenever feasible.
Results: The age of patients ranged from 5–11 years. The mean post-operative follow-up time was 
six months from the time of IOL insertion. Improvement in visual acuity 6 lines was achieved 
in four patients (mean visual acuity of 20/70 at six months). Improvement in stereoacuity was 
noted in all six patients (from total mean zero seconds-arc to six-months post-operative mean 
of 500 seconds-arc by randot stereoacuity testing). Improvement of 2 lines of visual acuity 
lines was achieved in the other two patients. No patient lost any lines of visual acuity. Enhanced 
physical activity, coordination, and improved social interaction were noted in patients and were 
reported by the parents. No intra/post-operative complications were noted.
Discussion: Irreversible or intractable amblyopia secondary to severe anisometropic myopia 
is a serious medical concern in the pediatric population. Failure of compliance with contact 
lens therapy consistently leads to visual loss. Anterior chamber phakic IOLs may provide a 
safe alternative in treatment of noncompliant anisometropic myopic patients who do not accept 
spectacle wear or contact lens therapy.
Conclusion: To reduce or eliminate highly significant anisometropic myopia in children who 
are noncompliant with traditional medical treatment, phakic anterior chamber IOL implantation 
may be considered as an alternative modality of treatment.
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Introduction
The prevalence of myopia has been reported to be one in three in the US, affecting some 
seventy million people.1 Unilteral myopia, or anisometropia, starts early in life.2 If severe 
(anisometropic myopia 6–8 Diopters) and left untreated, anisometropia may not only lead Clinical Ophthalmology 2009:1 368
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to visual loss but it may as well lead to the disruption of binocular 
fusion. Hence, strict compliance with spectacle correction or 
contact lens therapy is essential for the amblyopia treatment to 
be successful, restoring binocular fusion and stereopsis.
In high pediatric anisometropic ametropia of 10 D, spec-
tacle correction may not be the most desirable medical therapeu-
tic option due to induction of aniseikonia and secondary loss of 
binocular fusion.3,4 Therefore, contact lens wear for treatment 
of anisometropia may seem to be the best preferred method of 
intervention.3 However, many children resist contact lens wear 
and a number of parents find placement of contact lenses in tod-
dlers to be extremely challenging, difficult, and unrewarding. 
As a result, some authors have advocated surgical methods 
ranging from clear lens extraction and refractive lens exchange 
to corneal refractive laser ablations.5,6 Yet these procedures may 
carry serious short- or long-term post-operative side effects 
including increased risks for central corneal-opacification 
and/or off-visual axis laser-ablation patterns.5
More recently, a few individual case reports set outside 
the US have been published for both phakic anterior chamber 
(AC) and posterior chamber (PC) intraocular lens implanta-
tion for the treatment of severe anisometropia myopia.6–9 
Implantation of phakic AC intraocular lens without removal 
of natural lens is an innovative approach in treatment of 
high anisometropia as the method will have reversibility and 
potentially fewer side effects in comparison to other currently 
existing and proposed surgical techniques such as corneal 
laser procedures or clear lens extraction in terms of reduced 
risk for retinal detachment and/or corneal haze/scar.
In this retrospective pilot study, we attempt to investi-
gate post-operative outcome and side effects of Verisyse™ 
phakic IOL (Abbott Medical Optics, Inc., Irvine, CA) for 
the treatment of severe anisometropic myopia (-8) in early 
childhood where the traditional medical treatment has been 
employed and failed.
Design and methods
Six anisometropic myopic pediatric patients (aged 5–11) 
in one practice were identified through retrospective chart 
review. All surgeries were done during 2005–2006. Four male 
and two female patients were identified. None of the patients 
were compliant with spectacle wear and contact lens therapy 
despite strong medical counseling and support. All patients 
suffered from dense amblyopia. Comprehensive discussion 
with parenst was thoroughly undertaken pre-operatively and 
informed consent with Food and Drug Administration (FDA) 
off-label use (of this form of IOL) was carefully obtained 
by all parents. All patients underwent Verisyse™ phakic 
IOL implantation in the more myopic eye by one surgeon 
(AP). Pre- and post-operative (on days 1, 3, 7, 30 and at 2, 
4, and 6 months) visual acuity, anterior/posterior segment 
examination, stereoacuity, axial biometry measurements, 
cycloplegic refraction, and endothelial cell counts (ECC) 
were performed in all patients whenever feasible during 
office visits or at examinations under anesthesia. Part-time 
occlusion treatment of two hours/day was initiated two weeks 
subsequent to IOL insertion in all patients for a period of 12 
weeks. Further part-time occlusion treatment was adjusted 
based on the visual acuity response of each patient.
Surgical technique
Verisyse™ phakic IOL implantation was performed by a 
single surgeon (AP). Surgical technique followed the proce-
dural implantation described by the Abbott Medical Optics 
(AMO) guidelines (Abbott Medical Optics, Inc., Irvine, CA). 
The superior incisions were carried as clear corneal. Choice 
of Verisyse™ phakic IOL optic size was determined based on 
the anterior chamber depth. In the eyes with anterior chamber 
depth of greater than 3.20 mm, 5.5 mm optic-size implant was 
selected (Table 2). Four 10-vicreyl (Ethicon, West Somerville, 
NJ) sutures were used to close the wound at the conclusion of the 
procedures. Subconjunctival injections of marcaine, dexamethe-
sone, and ancef® into inferior fornix were done at the conclusion 
of the procedures. Post-operative medical regimen included 
administration of topical Pred Forte® and Tobradex® ointment 
alternating every two hours for the first two weeks. After two 
weeks, tobradex ointment was discontinued and the Pred Forte 
was gradually tapered over the following four weeks.
Results
Six patients ranging in age from 5–11 years had a mean 
pre-operative visual acuity of 20/400 or worse. Four 
male and two female were included in this study. Mean 
post-operative follow-up time was six months following AC-
IOL implantation. Improvement of visual acuity (6 lines of 
Allen/Snellen) in four patients. All patients gained gross ste-
reoacuity. Two other patients displayed improvement of 4 
lines of visual acuity. No patients lost any line of visual acuity 
(Tables 1 and 2). Pre and post-operative cycloplegic refraction 
and visual acuity are summarized in (Tables 4 and 5).
All patients showed enhanced physical activity, improved 
coordination and social interaction, which were reported by 
all parents through direct questinaoire about eight weeks 
from the surgery and remained so until the end of the 
six-months study period. No intra/post-operative serious or 
vision-threatening side effects were noted. Retrospectively, one Clinical Ophthalmology 2009:1 369
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patient with an intra-operative cyclotorsion showed phakic 
IOL-claws to be at 10 and 4 o’clock post-operatively.
Post-operative direct clinical assessment of anterior 
chamber showed mean of 1 + cell/flare inflammation on day 1 
for all patients and it subsided to trace cell by the end of first 
week. By the second week, no cells or active inflammation 
was observed in any of our patients.
Although one patient acquired oblique corneal astigmatism, 
which gradually decreased over a six-month period, visual 
acuity was still better by two lines at the end of our follow-up 
period. At the end of the six-month follow-up period, all patients 
showed a 3%–7% endothelial cell loss in the phakic IOL eye; 
however, the rate of cell loss had stabilized in three patients from 
the three- to six-month examinations. All patients were strongly 
urged and instructed to avoid eye-rubbing. The greatest rate of 
endothelial cell loss had occurred during the first three post-
operative months (Table 3). No patient required re-operation 
or IOL-explantation. Patients’ parents were all pleased with the 
outcome of surgery. They pointed to lack of further requirement 
for contact lens wear, improved vision, and enhanced physical 
coordination as their main subjective satisfaction points.
Discussion
Intractable amblyopia secondary to severe long-term untreated 
anisometropic myopia is a serious medical concern in the 
pediatric population. Failure of compliance with contact 
lens therapy or spectacle correction may lead to permanent 
long-term visual loss with tremendous negative social and 
financial impact on both the society and the individual families. 
A variety of surgical options have been advocated for the 
treatment of severe anisometropic myopia including lensec-
tomy, clear lens extraction, and more recently corneal laser 
ablative procedures with the ultimate measure of success 
representing improvement of visual acuity in the absence of 
adverse outcomes or side effects.10 Despite the profound suc-
cess of refractive laser surgery in adults, significant challenges 
persist in treatment of pediatric patients with refractive corneal 
laser surgery ranging from higher rate of best corrected visual 
acuity loss from corneal haze formation or off-center visual 
axis treatment to requirement for general anesthesia in the 
laser suite, and the meticulous post-operative cooperation of 
the patient to avoid eye rubbing to reduce incidence of flap 
displacement in LASIK-treated patients.6 Long-term myopic 
regression has also been observed.6 Such disadvantages have 
led to exploration for alternative surgical techniques for treat-
ment of high myopic anisometropia in children. The clinical 
application of phakic IOL for treatment of severe anisome-
tropia was first described by Lesueur and colleagues with the 
use of ICL STAAR.6 Long-term follow up of such patients 
have shown substantial functional improvement in this group. 
Currently there are only a handful of peer-reviewed published 
studies in the literature on the subject of phakic IOL implanta-
tion for treatment of high anisometropia myopia in children.6–12 
As far as we are aware there has been only two other published 
Table 1 Review of patients’ pre-/post-op visual and stereoacuity
Patient     
#
Eye Age 
yr
Pre-op VA 
(cc best)
Pre-op 
SA
Post-op VA 
(6-months) sc
Post-op 
SA
Complications 
(post-operative)
1-M OD 10 20/200 0 20/80 800 None
2-M OD 11 20/400 0 20/50 400 None
3-F OS 6 20/200 0 20/80 400 None
4-M OS 10 20/400 0 20/50 400 None
5-M OD 6 CF 0 20/100 800 None
6-F OD 5 20/400 0 20/60 200 None
Abbreviations: SA, stereoacuity;   VA, visual acuity.
Table 2 Patients’ pre- and post-anterior chamber depth and axial length and IOL size
Patient  Eye Anterior Chamber depth Axial Length P-IOL
# OD OS OD OS Optic size
1 OD 3.20 3.38 26.32 22.00 5.5
2 OD 3.00 3.21 27.22 22.42 5.0
3 OS 3.00 3.20 23.86 25.66 5.5
4 OS 2.92 3.18 21.78 24.34 5.0
5 OD 2.83 3.00 24.56 21.91 5.0
6 OD 3.00 3.22 24.62 21.65 5.0
Abbreviation: IOL, intraocular lens.Clinical Ophthalmology 2009:1 370
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studies in the US on the investigation of anterior chamber 
phakic IOL for the treatment pediatric myopic anisomteropic 
ametropia.11,12 We additionally believe that there are significant 
advantages in using anterior chamber phakic IOLs for treat-
ment of severe anisometropic myopia in the pediatric patients 
as potential side effects of this procedure may be less than the 
refractive laser corneal-ablative procedures currently available 
for the treatment of myopia 10 D.
An advantage of anterior chamber phakic IOL (AC-pIOL) 
includes the farther distance of its sitting optic from the 
natural crystalline lens in comparison to posterior-phakic 
IOLs (PC-pIOL) hence reducing the risk of early or late onset 
lenticular-opacification. A disadvantage of AC-pIOL includes 
an ongoing corneal endothelial cell loss potentially attributing 
to the eventual corneal decompensation. Furthermore, although 
anterior chamber phakic-IOL (AC-pIOL) has firm iris enclava-
tion at the end-haptics, there is a potential risk for traumatic 
iris-haptic de-enclavation, hence a possibility for spontaneous 
lens dislocation.11
A few advantages of PC-pIOLs, on the other hand, include 
reduced risk for endothelial cell loss, a smaller corneal inci-
sion entry site for delivery into the anterior chamber, and no 
requirement for iris-haptic enclavation.13 The disadvantages of 
PC-pIOLs include increased risk for lenticular opacification due 
to inadvertent lenticular touch during the implantation and/or 
due to childhood eye rubbing.13 Other potential complications 
of PC-pIOLs, including papillary-block glaucoma and posterior 
dislocation of IOL, have also been reported in an European 
Clinical Trial with PRL group and other studies.15–17
Our study has been one of the first and largest pilot clinical 
series in the US to thoroughly investigate the variables of risks 
and benefits of anterior chamber phakic IOL in treatment of 
high anisometropic myopia in children.6–12 We also believe 
phakic IOL implantation employs several inherent properties 
which makes it ideal for treatment of high anisometropia 
myopia in comparison to corneal laser surgeries. Technique 
though distinct due to necessity of enclavation of haptics to 
iris is somewhat similar to IOL placement following cataract 
extraction and many pediatric ophthalmologists are already 
familiar with this form of surgery. Conscious central fixation 
is not necessary in phakic IOL implantation as is in laser abla-
tive procedures. The technique is reversible and in the cases 
of rapidly progressive myopia, phakic IOL exchange with a 
higher power IOL could be considered.
Despite the many advantages of phakic IOL, an essential 
similarity with clear lens extraction or corneal ablative pro-
cedures still exists which is the need for occlusion therapy. 
A very deliberate and careful selection process of patients 
with appropriate anterior chamber depth is a key factor in 
potentially reducing rate of ECC loss following the phakic 
anterior chamber IOL implantation. Patients need to be 
instructed as well to avoid any eye rubbing post-operatively. 
In cases where ECC cannot be determined and/or endothelial 
cell loss is disproportionally progressing, explantation of 
phakic IOL could be considered once a child reaches post-
amblyopic age and is no longer at risk for visual loss.
We believe eliminating the underlying anisometropic 
refractive error by placement of phakic IOL is the direct 
etiology for gradual improvement of best-uncorrected visual 
acuity in our pediatric patients over the six-month period of 
Table 3 Pre- and post-operative ECC in surgical eye (±200c)
Eye Pre- Post- Post- % loss Post- % loss
1-mo 3-mo 3-m 6-mo 6-mo
OD 3300 3200 3200 3.1% 3100 6.1%
OD 3000 2900 2800 6.7% 2800 6.7%
OS 3100 3000 2900 6.5% 2900 6.5%
OS 3300 3200 3200 3.1% 3100 6.1%
OD 3100 3000 3000 3.3% 2900 6.5%
OD 3500 3400 3400 2.9% 3300 5.7%
OS 3400 3300 3300 3.0% 3300 3.0%
Abbreviations: ECC, endothelial cell counts; mo, months.
Table 4 Post-operative refraction (cycloplegic)
Patient
#
Pre-op Cycloplegic Post-op refraction Target operative
Refraction (SE) (Six months) p-IOL Eye refraction
OD OS
1 -16.50 -1.50 -0.50 + 0.50 × 100 Plano
2 -17.00 -1.00 Plano Plano
3 +1.25 -13.50 -3.50 + 3.50 × 150 Plano
4 -1.50 -13.00 Plano + 1.00 × 90 Plano
5 -12.50 +2.00 -1.50 sph Plano
6 -13.50 +1.00 -0.50 + 1.00 × 90 Plano
Abbreviations: IOL, intraocular lens; SE, spherical equivalent.Clinical Ophthalmology 2009:1
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this study. Two other independent studies have proven by 
eliminating anisometropia solely with spectacle correction 
would improve the visual acuity in amblyopic children, 
hence supporting our theory.18,19 Furthermore, we feel our 
lack of ability to achieve a better visual acuity gain is related 
to the long-standing pre-existing amblyopia in our patients’ 
population. We deem further studies are needed to assess 
whether a better visual acuity improvement could be attained 
if phakic IOL implantation is performed at an earlier age in an 
uncooperative child prior to the onset of amblyopia.
Therefore, at this point we advocate larger prospective 
clinical trials with longer follow-up time to conclusively dem-
onstrate the efficacy of phakic IOL as an effective alternative 
method of treatment for non-compliant to medical treatment 
in severe anisometropic myopic pediatric patients. Anterior 
chamber phakic intraocular lens implantation without removal 
of the natural lens of children could ultimately become an ideal 
alternative treatment of high anisometropia in noncompliant to 
contact lens patients. The method will have reversibility as well 
as stability and may have fewest side effects in comparison to 
other currently proposed and existing surgical techniques.
Conclusion
To reduce or eliminate highly significant anisometropic 
myopia (-8 D) in young children with secondary amblyopia 
who have failed the conventional medical treatment with 
contact lenses or spectacle correction with binocular fusional 
loss, AC-pIOL implantation may be considered as an 
alternative form of treatment.
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Table 5 Mean preoperative and postoperative refraction and visual 
acuity pre-op and six months post-op
Pre-op 
best VA
Pre-op 
refraction
Post-op 
sc
Post-op 
refraction
Mean Mean and 
range
VA mean Mean (SE)
20/500 -14.33 ± 2.5 20/70 -0.50 ± -1.25
Abbreviations: SE, spherical equivalent;   VA, visual acuity.